The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...

Dispatch and carefully placed it inside my copy of And The Band Played On: Politics, People, and the AIDS Epidemic – his most ...

These young people are much more likely to experience treatment failure than ... July 2, 2024 — A major challenge in developing a vaccine for HIV is that the virus mutates fast -- very fast.

New research presented at the American Academy of Ophthalmology’s Cornea Subspecialty Day is part of the part of the 8-year ...

ATI-1701 provides full protection against lethal tularemia in animal models after one yearCompany to provide update on tularemia vaccine ...

Today's health news includes highlights from the STAT Summit, a new option for people with HIV who need kidneys, and GLP-1s ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...